Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEpe Special Opp Regulatory News (ESO)

Share Price Information for Epe Special Opp (ESO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 174.00
Bid: 170.00
Ask: 178.00
Change: 0.00 (0.00%)
Spread: 8.00 (4.706%)
Open: 174.00
High: 175.00
Low: 174.00
Prev. Close: 174.00
ESO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment

13 Nov 2020 07:00

RNS Number : 2009F
EPE Special Opportunities Limited
13 November 2020
 

EPE Special Opportunities Limited

 

Investment

 

 

EPE Special Opportunities Limited ("ESO" or the "Company") is pleased to announce that on 12 November 2020 it completed a $2.5 million investment in a segregated account of Prelude Structured Alternatives Master Fund LP ("Prelude"), satisfied by cash payment.

 

The Prelude account is advised by Atlantic Capital Management Limited ("ACML") and will invest in distressed credit opportunities, targeting a fund level gross annual return of 6-8%. The Company will invest in the Prelude junior tranche and will benefit from a leveraged position, receiving an equity-like return. The investment strategy of the Prelude account will benefit from increased opportunities generated by the default cycle expected in credit markets over the coming period.

 

EPIC Private Equity LLP ("EPE"), the investment advisor to the Company and a related party, has undertaken, subject to regulatory approval, to acquire a controlling interest in ACML, the sub-advisor of the Prelude account.

 

The Company will hold its investment in Prelude through ESO Alternative Investments LP ("ESO AI LP"). ESO will not pay any management or performance fees to ACML.

 

ESO is the sole investor in ESO AI LP, a vehicle which holds the Company's primary and secondary fund investments. ESO AI LP's acquisition will diversify the Company's asset class exposure, in line with the Company's stated investment strategy.

 

The person responsible for releasing this information on behalf of the Company is Amanda Robinson of Langham Hall Fund Management (Jersey) Limited.

 

Enquiries:

 

EPIC Private Equity LLP

+44 (0) 207 269 8865

Alex Leslie

Langham Hall Fund Management (Jersey) Limited

+44 (0) 153 488 5200

Amanda Robinson

Cardew Group Limited

+44 (0) 207 930 0777

Richard Spiegelberg

Numis Securities Limited

+44 (0) 207 260 1000

Nominated Advisor:

Stuart Skinner

Corporate Broker:

Charles Farquhar

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBTBJTMTJBTPM
Date   Source Headline
14th Jun 20245:00 pmRNSResult of AGM
16th May 20247:00 amRNSNotice of AGM
13th May 20247:00 amRNSNet Asset Value(s)
30th Apr 20247:00 amRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSNet Asset Value(s)
9th Apr 20247:00 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
9th Apr 20247:00 amRNSPosting of Report & Accounts
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSAnnual Financial Report
5th Mar 20247:00 amRNSHolding(s) in Company
13th Feb 20246:00 pmRNSDirector/PDMR Shareholding
8th Feb 20244:45 pmRNSTrading Update
8th Feb 20247:00 amRNSInterest Payment on Unsecured Loan Notes
10th Jan 20247:00 amRNSNet Asset Value(s)
20th Dec 20237:00 amRNSHolding(s) in Company
20th Dec 20237:00 amRNSHolding(s) in Company
14th Dec 20237:00 amRNSNet Asset Value(s)
9th Nov 20237:00 amRNSNet Asset Value(s)
26th Oct 20236:29 pmRNSDirector/PDMR Shareholding
17th Oct 20236:30 pmRNSHolding(s) in Company
10th Oct 20234:30 pmRNSNet Asset Value(s)
3rd Oct 20236:00 pmRNSDirector Retirement
20th Sep 20237:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSHalf-year Report
4th Sep 20235:00 pmRNSHolding(s) in Company
1st Aug 20237:00 amRNSHolding(s) in Company
1st Aug 20237:00 amRNSInterest Payment on Unsecured Loan Notes
26th Jul 20237:00 amRNSUpdate on Share Buy Backs
24th Jul 20237:00 amRNSTransaction in Own Shares
24th Jul 20237:00 amRNSExtension of Unsecured Loan Notes
21st Jul 20237:00 amRNSTransaction in Own Shares
19th Jul 20239:30 amRNSAnnouncement of ZDP Share Buybacks
18th Jul 202310:00 amRNSPortfolio Update
11th Jul 20237:00 amRNSNet Asset Value(s)
30th Jun 20237:01 amRNSProposed Extension of Unsecured Loan Notes
30th Jun 20237:00 amRNSResult of AGM
12th Jun 20237:00 amRNSNet Asset Value(s)
19th May 20237:00 amRNSNotice of AGM
17th May 20237:00 amRNSPosting of Annual Report and Accounts
12th May 20237:00 amRNSHolding(s) in Company
12th May 20237:00 amRNSDirector/PDMR Shareholding
12th May 20237:00 amRNSVesting - Share Matching Scheme/PDMR Shareholdings
11th May 20237:00 amRNSNet Asset Value(s)
20th Apr 20237:00 amRNSHolding(s) in Company
18th Apr 20237:00 amRNSTransaction in Own Shares
13th Apr 20237:00 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSNet Asset Value(s)
21st Mar 20237:04 amRNSAnnual Financial Report
21st Mar 20237:00 amRNSAnnual Financial Report
6th Feb 20237:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.